| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/07/2010 | US20100004262 Pharmaceutical compositions of aripiprazole |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004259 Tartrate Salt of (7S)-7-[(5-Fluoro-2-Methyl-Benzyl)oxy]-2-[(2R)-2-Methylpiperazin-1-YL]-6,7-Dihydro-5H-Cyclopenta[B]Pyridine |
| 01/07/2010 | US20100004258 Novel Heterocyclic NF-kB Inhibitors |
| 01/07/2010 | US20100004256 Heteroaryl-fused macrocyclic pyrimidine derivatives |
| 01/07/2010 | US20100004251 Dopamine-Agonist Combination Therapy For Improving Sleep Quality |
| 01/07/2010 | US20100004246 Novel triazinedione derivatives as gabab receptor modulators |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004240 Indole Compounds |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004228 calcitonin gene related peptide antagonists such as [(3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-[4-[1-(3-ethoxy-3-oxopropyl)piperidin-4-yl]piperidin-1-yl]-1-oxopropan-2-yl]4-(3-oxo-5-phenyl-1H-1,2,4-triazol-2-yl)piperidine-1-carboxylate; headaches; diabetes; irritable bowel syndrome; hot flashes |
| 01/07/2010 | US20100004226 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| 01/07/2010 | US20100004220 Indenoisoquinolinone Analogs and Methods of Use Thereof |
| 01/07/2010 | US20100004204 Ros-sensitive iron chelators and methods of using the same |
| 01/07/2010 | US20100004191 Compositions of S-adenosyl-L-methionine. |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/07/2010 | US20100003672 Cdna for human methylenetetrahydrofolate reductase and uses thereof |
| 01/07/2010 | US20100003321 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/07/2010 | US20100003320 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
| 01/07/2010 | CA2761288A1 Pain-relieving compositions of furoxan no donors and uses thereof |
| 01/07/2010 | CA2731790A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729720A1 Benzothiophene alkanol piperazine derivatives and their use as antidepressant |
| 01/07/2010 | CA2729710A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
| 01/07/2010 | CA2729681A1 Heterocyclic derivatives as modulators of ion channels |
| 01/07/2010 | CA2729595A1 Combinations comprising mglur modulators for the treatment of parkinson's disease |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/07/2010 | CA2729253A1 Novel process |
| 01/07/2010 | CA2729246A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity |
| 01/07/2010 | CA2728681A1 Adenine receptor ligands |
| 01/07/2010 | CA2728563A1 Use of mifepristone for the treatment of amyotrophic lateral sclerosis |
| 01/07/2010 | CA2726999A1 New drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/07/2010 | CA2633585A1 Treatments for any and all mental/brain neuron/spinal cord illness |
| 01/06/2010 | EP2141168A1 Heteroaryl derivatives |
| 01/06/2010 | EP2141166A1 Adenine receptor ligands |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141148A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 01/06/2010 | EP2140900A1 Method of Demand Valve Oxygen Therapy for Rapid Abort of Cluster Headache |
| 01/06/2010 | EP2140881A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/06/2010 | EP2140868A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments associated with or caused by chemotherapy |
| 01/06/2010 | EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2140863A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of neurological disorders |
| 01/06/2010 | EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2140000A1 Method of enhancing migration of neural precursor cells |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139897A1 Crystalline and amorphous forms of naltrexone hydrochloride |
| 01/06/2010 | EP2139896A1 Pyrimido [4, 5-d]azepine derivatives as 5-ht2c agonists |
| 01/06/2010 | EP2139891A1 4-substituted azaadamantane derivatives and methods of use thereof |
| 01/06/2010 | EP2139880A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor |
| 01/06/2010 | EP2139858A1 Piperidinone carboxamide derivatives as p2x7 modulators |
| 01/06/2010 | EP2139857A1 Sub-type selective azabicycloalkane derivatives |
| 01/06/2010 | EP2139851A2 Substituted amide derivatives |
| 01/06/2010 | EP2139848A1 Deuterium labelled ketamine |
| 01/06/2010 | EP2139836A1 Perfluoroketone compounds and uses thereof |
| 01/06/2010 | EP2139525A1 Fusion protein capable of degrading amyloid beta peptide |
| 01/06/2010 | EP2139497A2 Methods for treating nervous system injury and disease |
| 01/06/2010 | EP2139496A2 Oligonucleotide compositions for the treatment of alzheimer's disease |
| 01/06/2010 | EP2139485A2 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| 01/06/2010 | EP2139481A1 1-ý(2'-substituted)-piperazin-1'-yl¨-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents |
| 01/06/2010 | EP2139479A2 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression |
| 01/06/2010 | EP2139467A2 Neuroprotection in demyelinating diseases |
| 01/06/2010 | EP2139466A2 Magnesium compositions and uses thereof |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP2139334A1 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof |
| 01/06/2010 | EP2139332A1 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 01/06/2010 | EP1742624B1 Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| 01/06/2010 | EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/06/2010 | EP1575938B1 Compounds having selective inhibiting effect at gsk3 |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP0934281B1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators |
| 01/06/2010 | CN101619057A N-substituted piperidine derivatives as serotonin receptor agents |
| 01/06/2010 | CN100577798C Formula constituted by cytokine and compound, its action of promoting nerve regeneration and action of researching and diagnosing nervous system disease |
| 01/06/2010 | CN100577666C Thienopyridines as allosteric potentiators of the M4 muscarinic receptor |
| 01/06/2010 | CN100577664C Spirocyclic cyclohexane derivatives |
| 01/06/2010 | CN100577657C Amorphous object of cinnamide compound |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/06/2010 | CN100577193C Health product for sobering-up |
| 01/06/2010 | CN100577167C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 01/06/2010 | CN100577160C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 01/06/2010 | CN100577150C Abuse-proof dosage form |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642362 Compounds as semaphorin inhibitors |
| 01/05/2010 | US7642283 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing the complex to a compound such as 6-bromo-3-methylene-chroman-4-one |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642274 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist |
| 01/05/2010 | US7642267 Benzimidazole and pyridylimidazole derivatives |
| 01/05/2010 | US7642262 Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/05/2010 | US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2429162C Methods and compositions for enhancing cellular function through protection of tissue components |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |